Multiple Myeloma

Thursday, February 23, 2017 - 5:00pm

The U.S. Food and Drug Administration approved a new indication for the oral drug lenalidomide (brand name Revlimid) as a maintenance therapy for multiple myeloma patients following autologous hematopoietic stem cell transplant (ASCT), also known as autologous blood and marrow transplant (BMT).

Wednesday, March 26, 2014 - 7:58am

March is Myeloma Awareness Month. At Roswell Park we’re working year-round to uncover new ways of understanding this disease in order to develop new treatment methods and improve long-term survival rates for patients.

Tuesday, May 7, 2013 - 1:24pm

Roswell Park recently honored March as Myeloma Awareness Month and I want to share with you some of the exciting research being done regarding multiple myeloma treatment.